Hyderabad in Telangana and Vizag in AP to become two major hubs for bulk drug manufacturing in south India
With the initiation of Pharma City project in Hyderabad and establishment of two more clusters in addition to the existing Jawaharlal Pharma City in Vishakhapatnam (Vizag), Hyderabad in Telangana and Vizag in Andhra Pradesh have become two major hubs for bulk drug manufacturing in south India.
In Telangana state, Hyderabad is already known as the bulk drug manufacturing zone of India. However, recently the state government of Telangana has decided to establish a mega integrated pharmaceutical cluster on the outskirts of Hyderabad.
With a spread of 19,000 acres, the Mega Pharma City project on the outskirts of Hyderabad is going to give a new boost to the already well established bulk drug sector in the state. “Through this Pharma City project, we are expecting an overall investment of more than Rs.64,000 crores in the coming days, in addition to creation of nearly 2 lakh jobs. The main objective of this new Phama City cluster is to facilitate the drug manufacturers to have a plug and play sort of platform and thereby drastically reduce the cost of manufacturing and ensure affordable medicines to the public,” says K Taraka Rama Rao, minister for industries, commerce and information Technology, government of Telangana.
The state government has already procured 9,000 acres of land out of proposed 19,000 acres and the works have already started under the first phase of the project. The Telangana State Industrial and Infrastructure Development Corporation Limited (TSIIDCL) has already started the construction of laying roads, drainage, common effluent treatment plants and power lines in the proposed project. The Pharma City is going to be developed into a one stop shop for all the healthcare requirements, wherein it will not only have bulk drug manufacturing, formulation, research institutes, healthcare equipment manufacturers and other device makers, but it will also encompass service providers to the pharmaceutical firms. “Already the state government had acquired 9,000 acres of land and has handed it over to the TSIIDCL, works under phase-1 have already started,” informed EV Narasimha Reddy, vice chairman and managing director of TSIIDCL.
While in Andhra Pradesh, the state government has already drafted comprehensive action plans to set up pharma clusters in all the 3 regions of Costa, Andhra and Rayalaseema. To begin with, initiation for the beginning of two big pharma clusters, one in Visakhapatnam (Vizag) and the second one in Nellore district are on the cards. Both the new clusters are expected to spread over 2,000 and 3,500 acres respectively.
Currently, the JPNC Pharma City at Vizag is full with units and the second locality in the same region is expected to house a bigger pharma city.
In the northern coastal region, Nakkapally in Vijaynagaram district is also having a big plant near to Anakapally industrial cluster. Adding to this, the state government’s plan to build another cluster in Nellore is also being looked as positive signals.